Cambridge Investment Research Advisors, Inc.
Position in OGN — Organon & Co.
CIK 1419186
FAIRFIELD, IA
Position in OGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$176,236
+$81,720 QoQ
Shares Held
13,016
-17.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#243
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cambridge Investment Research Advisors, Inc. holds $708,681,337 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
181,813 | $218,071,984 | |
| 2 | ABBV |
AbbVie Inc.
|
566,381 | $142,524,114 | |
| 3 | JNJ |
Johnson & Johnson
|
486,640 | $123,591,960 | |
| 4 | MRK |
Merck & Co., Inc.
|
469,217 | $60,294,384 | |
| 5 | PFE |
Pfizer Inc
|
1,820,575 | $43,839,446 | |
| 6 | AMGN |
Amgen Inc
|
107,825 | $39,045,589 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
434,411 | $25,030,761 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
144,124 | $18,208,626 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,236 | 13,016 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $94,516 | 15,779 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $154,678 | 21,573 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $366,793 | 34,344 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $424,922 | 43,897 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $642,429 | 43,145 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $640,097 | 42,902 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $988,427 | 51,669 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,034,254 | 49,964 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $727,748 | 38,710 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $288,068 | 19,977 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $419,400 | 24,159 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $464,500 | 22,321 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $660,629 | 28,088 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $793,603 | 28,414 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $747,396 | 31,940 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,072,743 | 31,785 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,131,522 | 32,394 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,047,388 | 34,397 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,335,110 | 40,717 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,164,949 | 38,498 | Shares | Sole | 2021-08-10 | |
| No filing history on record for this holder in this stock. | ||||||